Utility of absolute lymphocyte count as a surrogate marker of CD4 cell counts: Is it useful?

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4054804)

Published in Med J Armed Forces India on August 06, 2013

Authors

Amitabh Sagar1, Abhishek Pathak2, Vikas Ambiya3, Nardeep Naithani4, Biju Vasudevan5, Sunil Agrawal6

Author Affiliations

1: Associate Professor, Dept of Internal Medicine, Armed Forces Medical College, Pune 40, India.
2: Graded Specialist (Medicine), 166 Military Hospital, C/o 56 APO, India.
3: Graded Specialist (Ophthalmology), Military Hospital, Shillong, India.
4: Professor & Head, Dept of Internal Medicine, Armed Forces Medical College, Pune 40, India.
5: Classified Specialist (Dermatology), Command Hospital (Southern Command), Pune 40, India.
6: ADH, 33 Corps, C/o 99 APO, India.

Articles cited by this

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet (2004) 3.59

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med (2004) 3.05

Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS (2003) 2.52

Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2004) 1.66

Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother (2007) 1.45

Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 1.39

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Antivir Ther (2003) 1.34

Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy. J Glob Infect Dis (2011) 0.98

Total lymphocyte count and World Health Organization pediatric clinical stage as markers to assess need to initiate antiretroviral therapy among human immunodeficiency virus-infected children in Moshi, Northern Tanzania. Pediatr Infect Dis J (2009) 0.95

Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya. BMC Infect Dis (2011) 0.83